Events
Hide Event DetailsPresenters:
- Larry Merlo, President & Chief Executive Officer, CVS Health
- Dave Denton, Executive Vice President & Chief Financial Officer, CVS Health
- Jon Roberts, Executive Vice President & President, CVS Caremark
- Alan Lotvin, MD, Executive Vice President, CVS Specialty
- Helena Foulkes, Executive Vice President & President, CVS Pharmacy
Hide Event DetailsFeatured presenter:
- Anita M. Allemand, PharmD, Senior Vice President, Enterprise Product Innovation and Development, CVS Health
Highlights:
- General Session: Market-Driven Approaches to Managing the Rise in Drug Prices
- Presenter: Anita M. Allemand, PharmD, Senior Vice President, Enterprise Product Innovation and Development, CVS Health
In the last year, drug price increases have been in the double digits in the U.S., and the increases are larger and occurring more frequently than in previous years. This issue has dominated the national media through much of 2016, led to increased congressional scrutiny, and even pushed drug pricing into the presidential campaign. But there are market-driven approaches that can help moderate the rise in prices. In fact, now more than ever, health plans and large employers need a comprehensive approach to managing rising drug prices that both improves patient care and reduces unnecessary spending.
Hide Event DetailsHighlights:
- Think "Consumers" Instead of "Patients"
Featured presenter:
- Alan Lotvin, Executive Vice President Specialty Pharmacy, CVS Health
SXSW Conference
Featuring a variety of tracks that allow attendees to explore what’s next in the worlds of entertainment, culture, and technology, SXSW proves that the most unexpected discoveries happen when diverse topics and people come together.
Think "Consumers" Instead of "Patients"
March 14, 2017 | 9:30AM – 10:30AM
More information about this session
Hide Event DetailsFeatured Presenter:
- Surya Singh, M.D., Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health
Highlights:
Innovation in Pharmacy Delivery: Value-Based Purchasing for Drugs
March 30, 2017
Presenters:
- Surya Singh, M.D., Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health
- Rena Conti, Ph.D, Departments of Pediatrics Hematology/Oncology and Health Studies, The University of Chicago
- Sarah Emond, Executive Vice President and Chief Operating Officer, Institute for Clinical and Economic Review
We often hear "you get what you pay for." However, that statement seems vastly oversimplified in a multifaceted drug industry where the cost of a single medication can be dictated and influenced by a number of factors. A value-based purchasing strategy, which ties payment to the manufacturer with drug efficacy, is touted as the next big solution to the pharmacy expenditure crisis. Watch experts discuss and debate the merits of value-based purchasing and its ability to control health care costs for the long term.
Hide Event Details2017 Forum
Learn from CVS Health executives and industry thought leaders as they share insights and solutions. The 2017 Forum is focused on what matters most to you – driving affordable, accessible and effective care.
Featured presenters include:
- Larry Merlo, President and CEO
- Jon Roberts, Executive Vice President and Chief Operating Officer
- Troyen Brennan, MD, Executive Vice President and Chief Medical Officer
- Alan Lotvin, MD, Executive Vice President Specialty Pharmacy
- Steve Gold, Executive Vice President and Chief Information Officer
- Helena Foulkes, Executive Vice President and President CVS Pharmacy
- Surya Singh, MD, Vice President and Chief Medical Officer, Specialty Pharmacy
- Casey Leonetti, Head of PBM Innovation
Hide Event DetailsFeatured Presenters:
- Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
- Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health
Highlights:
Applying Innovative Technology to Enhance the Effectiveness of a Specialty Management Model
May 8, 2016, 12:30 - 1:30pm
Presenter: Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
By 2020, specialty drugs will represent 55% of all drug costs, with half falling under the medical benefit. Disparate benefit systems can contribute to limited visibility into a health care payor’s true specialty drug spend, and lead to complex and fragmented care. Using automated technology to manage across medical and pharmacy benefits can help generate incremental savings opportunities while improving patient outcomes. This session will explore how technology can help transform data into actionable interventions to manage the health of complex populations, improve clinical outcomes, and deliver lowest net cost for payors.
Proactive Pipeline Management to Help Address Growing Trend
May 9, 2017, 1:00-2:00 pm
Presenter: Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health
With specialty drugs dominating the pipeline for expensive and complex conditions including autoimmune, oncology, cystic fibrosis and even high cholesterol, it is important to have a strong foundational knowledge of the changing market. Some treatment regimens for some of the most expensive specialty drugs cost up to $400,000, while the legal and regulatory treatment of these pricey and often life-saving medications add to management complexity. Learn about key strategies to help mitigate unnecessary drug spend.
Hide Event DetailsFeatured Presenter
- Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
Hide Event Details Hide Event DetailsFeatured Presenter:
- Surya Singh, MD, Vice President & Chief Medical Officer, Specialty, CVS Health
Highlights:
Value-Based Pharmacy Management
September 12, 2017, 3:15 – 4:15 pm
In other consumer goods industries, consumers do not routinely pay for something that does not work or is only partially effective. In healthcare, however, this has not historically been the norm. However, we are increasingly seeing a movement toward value-based healthcare and away from fee-for-service reimbursement models. This is evidenced by greater emphasis on alternative payment models, including Accountable Care Organizations (ACOs), which incentivize high-quality care and better patient outcomes. In the realm of pharmacy, new models are emerging that tie reimbursement for a drug to the value delivered, not volume or a pre-set price. In this session, we will provide an overview of the emerging value-based pharmacy management models that aim to improve health outcomes and lower costs.
Hide Event Details Hide Event Details Hide Event Details Hide Event Details Hide Event DetailsFeature Presenter:
Tracy Bahl, CVS Health Executive Vice President of Health Plans, will be on a panel focusing on The Healthcare Delivery System of the Future.
Highlights:
- Improved data connectivity and rapidly-evolving technologies impact on care delivery systems around the world.
- Technological solutions that are the most in demand by the different players in the health ecosystem
- How data is reshaping and reinventing the care continuum
- What new capabilities are on the horizon
The panel will also explore what the delivery system of the future might look like, including the potential for data and technology to enhance the patient experience, improve outcomes, and lower costs, ultimately changing care as we know it.
Hide Event DetailsFeature Presenter:
- Josh Fredell, Senior Director, Specialty Product Development, CVS Health
Highlights:
Value-Based Pharmacy Management
Tuesday, March 6 | 2:10 pm - 3:00 pm
With high launch prices for new drugs and year-over-year price inflation, especially for specialty brand medications, the cost impact to payors is growing and new management tools are needed. Manufacturers are also obtaining multiple supplemental indications for drugs post-launch. CVS Health analysis shows that as many as 101 supplemental indications for existing drugs could be approved between 2017 and 2019. Value-based management strategies can help ensure a sustainable future for the pharmaceutical and health care market and enable payors to control costs, while providing an affordable benefit to their plan members. Choosing the appropriate approach will depend on therapeutic area, the goals of an organization, and how data can be used to meet health-outcome and cost-reduction goals. This session will focus on indication-based management.
Hide Event DetailsFeature Presenters:
- Surya Singh, MD, Vice President and CMO, Specialty, CVS Health
- Jon Roberts, Executive Vice President & Chief Operating Officer, CVS Health
Highlights:
- The Growth of Specialty Pharmacy: Key Trends to Consider
Monday, March 5 | 11:15 am - 11:45 am
As specialty continues to grow, estimated to reach $280B by 2021, market dynamics will have wide ranging impacts on how cost-effective care is delivered. During this session, Alan will address key trends he believes are crucial for the specialty pharmacy industry to address.
- Robust pipeline of specialty agents used to treat higher prevalence disease states create cost pressure, clinical promise
- Transformative therapies, like high-cost CAR T-cell products, present a challenging economic proposition in a fragmented U.S. market
- Advances in oncology testing creates complexity and opportunity for better patient care
- True generics and biosimilars are emerging as a significant factor in specialty management
- Managing Specialty Costs by Improving Patient Care
Tuesday, March 6 | 9:15 am - 9:45 am
Effectively managing the cost of specialty care requires a focus on more than drug costs alone. In this PBM leadership session, Jon will discuss benefit management strategies aimed at improving health outcomes and simplifying the health care experience, and why they are key to lowering spending overall. These strategies also require working closely with multiple stakeholders, including patients, payers, and providers.
Hide Event DetailsFeature Presenter:
Josh Fredell, CVS Health Senior Director of Specialty Product Development, will be speaking on Value Based Pharmacy Management.
Highlights:
- Improved data connectivity and rapidly-evolving technologies impact on care delivery systems
- Different strategic approaches to value based contracting
- How to measure the “success” of a value-based management approach
- The guardrails needed to ensure a successful value based pharmacy management strategy
Hide Event DetailsContaining Costs. Connecting Care. Engaging Members.
This is how we’re taking a stand to help shape the future of health care. CVS Health leaders and industry experts will share the strategies, programs and innovations that matter most for health care today... and tomorrow.
Featured presenters include:
- Larry Merlo, President and CEO, CVS Health
- Jonathan C. Roberts, Executive Vice President and Chief Operating Officer, CVS Health
- Troy Brennan, Chief Medical Officer, CVS Health
- Alan Lotvin, Executive Vice President, Specialty Pharmacy, CVS Caremark
- David Joyner, Executive Vice President, Sales and Marketing, CVS Caremark
- Tracy Bahl, Executive Vice President, Health Plans, CVS Caremark
Hide Event DetailsPlease visit us at our exhibit booth in the main conference meeting room.
Hide Event DetailsFeature Presenters:
- Rob O'Brien, R.Ph., Vice President, Specialty Solutions, CVS Specialty, CVS Health
- Andrew Krueger, M.D., Senior Medical Director, Accordant Health Services, CVS Health
Highlights:
- Innovation in Pharmacy and Health Care Delivery: Is Value Purchasing the Future of Pharmacy Reimbursement?
Thursday, April 19 | 10:30 - 11:30 am
Health plans, pharmacy benefit managers (PBMs), pharmaceutical manufacturers, and employers are beginning to implement value-based drug purchasing arrangements like outcomes-based pricing; indication-based pricing; indication-based formularies. Rob O'Brien joins a panel of pharmacy experts to discuss how value-based management strategies can help ensure drug prices align with the value they deliver. - Transforming the Pharmacy Experience: A Panel of Patients, Manufacturers, PBMs and Providers
Friday, April 20 | 10:45 - 11:45 amDr. Krueger joins this panel to discuss the patient pharmacy experience. Whether it’s receiving specialty medications, choosing the right medication with a treating physician, exploring alternative sites of care or finding ways to pay for it all, there is clearly a need to improve the experience for patients. This thought-provoking discussion of panelists represents each decision-point within the pharmacy supply chain.
Hide Event DetailsFeature Presenter:
- Glen Davis, MD, MBA, Medical Director, CVS Health
Highlights:
- Managing Atopic Dermatitis and Its Drug Spend
Tuesday, April 24 | 12:45 - 2:00 pmAtopic dermatitis affects approximately 17 million people in the U.S. This disease magnitude places a heavy burden on payers. With many treatment therapies available, and more on the way, how do payers assess the options to best improve patient outcomes and manage drug spend?
This session will provide an overview of atopic dermatitis and examine the financial and therapeutic impacts of medications recently approved by the FDA. It also will look at how payers can apply this information to inform trend management, and will provide an example of how one health plan manages drug spend for atopic dermatitis.
Please join us for Dr. Davis’ presentation and visit us at booth MR1 in the Boston Convention & Exhibition Center during AMCP’s Annual Expo hours.
Hide Event DetailsFeatured Presenter:
- Dr. Dick Creager MD, MPA, Medical Director, Emergency Medicine, CVS Health
Highlights:
- Successful Strategies to Battle Widespread Opioid Abuse
Wednesday, May 2 | 1:00 PM – 1:45 PMIt is well known that the human and economic costs of widespread prescription opioid abuse are profound. The U.S. accounts for 80 percent of the world’s consumption of opioid painkillers and 99 percent of hydrocodone. Without a doubt, addressing our nation’s opioid crisis calls for a multipronged effort involving many health care stakeholders – from physicians to pharmaceutical companies, and pharmacies to government officials.
Please join Dr. Creager for this important discussion and stop by booth 316 in the exhibit hall to meet the CVS Health team.
Hide Event DetailsFeatured Presenters:
- Theresa Juday, Senior Specialty Professional, CVS Health
- Coree Allen, PharmD, Clinical Advisor, CVS Health
Highlights:
- Specialty Pipeline: Helping to Monitor and Identify New Challenges and Opportunities
Tuesday, May 1 | 9:30 am - 10:30 amThere are approximately 220 new specialty drugs anticipated to be released in the next two years and the high cost for innovative drugs continues to drive specialty trend. In this environment, continuous monitoring of the specialty pipeline as well as understanding unique trend drivers is essential to ensure the ability to quickly adapt and proactively manage these factors. In this session, Theresa Juday and Coree Allen will discuss the current specialty pipeline and how CVS Health’s dedicated clinical teams leverage advanced analytics to stay ahead of new drug approvals and develop management strategies to help our clients prepare for the potential impact to their members and their plan.
Please join us for this specialty pipeline discussion and visit the CVS Health team at booth 400 in the exhibit hall.
Stay up-to-date on pharmacy benefit trends and payor solutions.
About CVS Health
Millions of times a day, we’re helping people on their path to better health—from advising on prescriptions to helping manage chronic and complex conditions. Because we’re present in so many moments, big and small, we have an active, supportive role in shaping the future of health care.
Resources
This page contains trademarks or registered trademarks of CVS Pharmacy, Inc. and/or one of its affiliates.
©Copyright 1999 - 2018 CVS Health